Sunday, November 15, 2026

Federal Reserve Holds Rates as Global Central Banks Split on Inflation Response

The Federal Reserve maintains interest rates at 3.5-3.75% with inflation above 2% for nearly five years, while the European Central Bank signals confidence in eurozone price stability. The transatlantic divergence creates currency pressures and forces multinational banks to adjust funding strategies as policymakers debate whether current rates remain restrictive.

From our archive, published before source-traceability. How we work

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
Federal Reserve Holds Rates as Global Central Banks Split on Inflation Response
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The Federal Reserve holds interest rates at 3.5-3.75% as U.S. inflation exceeds its 2% target for nearly five years. European Central Bank board member Joachim Nagel said the eurozone inflation picture "looks favorable," highlighting a transatlantic policy split that pressures currency markets and multinational bank funding strategies.

New York Fed President John Williams will consider rate cuts only after tariff impacts pass through the economy and inflation slows. Atlanta Fed President Raphael Bostic favors mildly restrictive rates, expecting 2026 growth to push prices higher. The Middle East conflict adds near-term inflation risks across energy and commodity markets.

Banks globally face margin compression. Higher-for-longer rates squeeze net interest income as deposit costs stay elevated while loan demand weakens. Regional U.S. banks and European lenders see profitability pressured as yield curves normalize slower than anticipated.

Credit markets reprice duration risk worldwide. Corporate treasurers with floating-rate debt face extended higher borrowing costs. Commercial real estate refinancings hit obstacles with rates above pre-pandemic levels in major markets including New York, London, and Frankfurt.

Services inflation remains the primary barrier to Fed rate cuts. Tariff uncertainties compound the challenge as businesses may pass costs to consumers. Minneapolis Fed President Neel Kashkari dismissed cryptocurrency proposals, calling explanations unclear and signaling regulatory caution as global financial institutions explore digital assets.

The policy divergence between the Fed and ECB affects cross-border capital flows. European banks with dollar funding needs face higher costs, while U.S. institutions adjust euro exposure strategies. Asian central banks watch both regions as they calibrate their own policy responses to persistent inflation.

Financial institutions plan for extended rate uncertainty across markets. Treasury management requires flexibility as the neutral rate debate continues in Washington and Frankfurt. Banks with commercial real estate exposure in major global cities face refinancing waves hitting elevated rate environments.

Markets now price fewer Fed rate reductions in 2026, resetting fixed income valuations and loan strategies across the global banking sector. The shift marks a departure from expectations of multiple cuts and forces portfolio adjustments at institutions from Wall Street to the City of London.

Source documents

Via News is a conduit. We point to the source documents behind this report: we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· February 18, 2026
    Markets bet on spring rate cut as inflation falls
  2. [2]News articleYahoo Finance· February 25, 2026
    'Raise Your Hand If You've Bought Or Sold Something With Bitcoin': Fed Official Reportedly Slams Crypto And Stablecoins As 'Utterly Useless'
  3. [3]News articleYahoo Finance· March 3, 2026
    Stock market today: Dow falls by 700 points, S&P 500 and Nasdaq sink as oil surges amid war worries
  4. [4]News articleYahoo Finance· November 6, 2025
    Stock market today: Dow, S&P 500, Nasdaq fall as Nvidia leads AI trade lower, jobs jitters reignite
  5. [5]News articleYahoo Finance· February 19, 2026
    Stock market today: Dow, S&P 500, Nasdaq slip as oil prices continue rally amid Iran-US tensions
  6. [6]News articleYahoo Finance· March 3, 2026
    Stock market today: Dow, S&P 500, Nasdaq trim losses but end sharply lower as Wall Street assesses Iran war worries
  7. [7]News articleNasdaq· February 25, 2026
    Stocks Settle Higher as AI Disruption Fears Ease
  8. [8]News articleNasdaq· February 21, 2026
    Stocks Settle Higher as SCOTUS Rejects President Trump’s Tariffs
  9. [9]News articleNasdaq· March 3, 2026
    Stocks Settle Lower on Iran War Anxiety
  10. [10]News articleNasdaq· March 3, 2026
    Stocks Sink as Crude Oil Surge Rattles Markets
  11. [11]News articleYahoo Finance· March 1, 2026
    US Job Growth Seen Moderating After Robust January
  12. [12]News articleUk· January 22, 2026
    Trump sues ‘woke’ JP Morgan for $5bn over debanking

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,997
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,997 facts checked against source5,580 source documents archived
Query this data → isubstrate.com